From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

First AI Antibody In Humans with Aulos' Aron Knickerbocker

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

Topical Ocular Biologics with Claris Bio's Clarke Atwell

C&G Regulatory Guidance with Lineage Cell Therapeutics' Brian Culley

True DEI Value in Biopharma with Arcellx's Rami Elghandour

Mission-Driven Dementia Funding with DDF's Jonathan Behr

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch

Dr. Randall Schatzman & The New Fundraising Norm

Fed Funding: Creative Capital Generation With James Thomas Coates, Ph.D.

Mission-Driven Dementia Funding with DDF's Jonathan Behr

Athersys' Ivor Macleod On Bringing Big-League Financial Experience To An Emerging Biotech

Fighting Blindness & Funding The Fight With Opus Genetics' Ben Yerxa, CEO

Public Sector Forged, Private Sector Tested With Renovaro BioSciences' Mark Dybul, M.D.

Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard

True DEI Value in Biopharma with Arcellx's Rami Elghandour

Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.

IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel

Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.

Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch

Epigenomic Programming With Omega Therapeutics' Mahesh Karande

TCRs In Personalized Oncology With BlueSphere Bio's Keir LoIacono

Antibody Cocktails With Immunome's Dr. Purnanand Sarma

BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.

Therapeutic Molecules From Moss with eleva's Andreas Schaaf And Björn Cochlovius, Ph.D.

Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.

Computational Drug Discovery With Gain Therapeutics' Matthias Alder

AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

Manipulating Milestones In Pandemic Times With AGTC's Sue Washer

Keeping Cell Therapy Clinicals On The Rails With Brian Culley

CMC Considerations For In-Human Studies With Drs. Edith Perez And Nathan Ihle

IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.

Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany

Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

Commitment To GMP With Dr. Shabbir Anik

The FDA's Progressive Appeal ft. Allan Shaw

Biotech Down Under with BiomeBank's Dr. Sam Costello

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

A Multiple Target Approach To Universal Influenza Vaccine Development

Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD

Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.

Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri

Building LEO Pharma's U.S. Presence with Brian Hilberdink

mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD

NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos

Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells

Acepodia's Approach To ACC & CAR Manufacturing Scalability

Filling A Vaccine Void With Cue Biopharma's Dan Passeri, J.D.